Aquestive Therapeutics Inc. (AQST)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

2,434,367 $11,271,119 -3% 1.07%
2.
Propel Bio Management

Leen Kawas And Richard Kayne

278,723 $8,608,753 -81% 4.56%
3.
Two Sigma Advisors

John Overdeck And David Siegel

1,778,655 $8,235,173 0.01%
4.
Sio Capital

Michael Castor

1,278,056 $5,917,399 -15% 1.12%
5.
D E Shaw

D. E. Shaw

1,162,357 $5,381,713 +2989% 0%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$3.55 26,825 $95,094.63 28,025 2026-11-10 Filing
$3.53 1,200 $4,236.00 1,200 2026-11-10 Filing
$0.81 5,000 $4,050.00 59,532 2022-06-14 Filing
$0.96 91,743 $88,073.28 193,702 2022-06-08 Filing
$0.96 45,871 $44,036.16 882,871 2022-06-08 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$4.22 25,000 $105,600.00 627,317 2026-10-15 Filing
$4.82 25,000 $120,487.50 652,317 2026-09-15 Filing
$5.22 8,750 $45,675.00 235,689 2026-09-09 Filing
$4.29 25,000 $107,167.50 585,574 2026-08-17 Filing
$4.00 20,369 $81,508.59 610,574 2026-07-16 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 9,810,958 $45,424,736 100%
2. 8,213,360 $38,027,858 0%
3. 7,426,471 $34,384,561 0.35%
4. 4,784,202 $22,150,855 0%
5. 3,481,391 $16,118,840 0%
News See All